AS01

AS01 has been studied in 4 papers since 2022: none in people yet, 1 in cells, 3 reviews; 2 in the past year. No study of it in people or animals has been published yet. The newest paper, Nov 14, 2026: “Immunosenescence and vaccine adjuvants in older adults: from immune decline to signal reconstitution strategies”.

Intervention

4 papers study it3 findingsUpdated

1 new paper in 30 daysSee all 4 papers on AS01

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

None of its findings points the other way.

Cells and humans: a single group. Worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: Cancer Institute NSW and others
  • 2 of 3 findings with company ties
  • Cells1

What did studies of AS01 find?

3

Studies of AS01 measured 3 outcomes: inflammation, dendritic-cell maturation and immunogenicity.

Inflammation

upin human cells1

1 study
  1. AS01 increases inflammation in human lymph node slices.

    “AS01 induced DC maturation and a strong proinflammatory cytokine response in intact LN slices”

    Cellsin human lymph node sliceslymph node

    Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent

    The Journal of clinical investigation

More on Inflammation

Dendritic-cell maturation

upin human cells1

1 study
  1. AS01 induces dendritic-cell maturation in human lymph node slices.

    “AS01 induced DC maturation and a strong proinflammatory cytokine response in intact LN slices”

    Cellsin human lymph node sliceslymph node

    Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent

    The Journal of clinical investigation

Immunogenicity

upin humans1

1 study
  1. AS01 improves immunogenicity in licensed vaccines.

    “Adjuvants AS01, MF59, AS03, and CpG-oligodeoxynucleotide, included in licensed vaccines, are effective in older human adults.”

    Reviewin licensed vaccines

    Precision Vaccine Adjuvants for Older Adults: A Scoping Review

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 12 papers in 12 months